established — replicated in humans, or settled by a regulator
every claim resolves to its source
All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.
created page created as 'Dulaglutide' with aliases Trulicity, LY2189265 · 2026-09-27 04:00 · somebody
kind set kind set to peptide: palette r1 · 2026-09-27 04:00 · somebody
identity withheld identity not published: PubChem gave no record that proves it is this substance · 2026-09-27 04:00 · somebody
fact added summary: Dulaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist given as a once-weekly subcutaneous injection. · 2026-09-27 04:00 · somebody
fact added history: In the REWIND trial of 9,901 people with type 2 diabetes followed for a median 5.4 years, dulaglutide reduced the compos · 2026-09-27 04:00 · somebody
fact added history: In the head-to-head AWARD-6 trial, once-weekly dulaglutide lowered HbA1c by 1.42% against 1.36% for once-daily liragluti · 2026-09-27 04:00 · somebody